We utilized GBM patient‐derived cell cultures with in vitro stem‐like properties and in vivo tumour‐initiating ability to characterize FOXG1 and TLE1 genomewide occupancy patterns and identify their direct target genes. This evidence concerns the gene TLE1 and glioblastoma.